Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Terenzio Ignoni"'
Autor:
Marco Sardella, Glyn Belcher, Calin Lungu, Terenzio Ignoni, Manuela Camisa, Doris Irene Stenver, Paolo Porcelli, Margherita D’Antuono, Nicola Gian Castiglione, Anna Adams, Giovanni Furlan, Ilaria Grisoni, Sarah Hall, Laura Boga, Valentina Mancini, Mircea Ciuca, David Chonzi, Brian Edwards, Arduino A Mangoni, Marco Tuccori, Elena Prokofyeva, Fabio De Gregorio, Mario Bertazzoli Grabinski Broglio, Bert van Leeuwen, Paola Kruger, Christian Rausch, Hervé Le Louet
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
The collection and assessment of individual case safety reports (ICSRs) is important to detect unknown adverse drug reactions particularly in the first decade after approval of new chemical entities. However, regulations require that these activities
Externí odkaz:
https://doaj.org/article/e2f577c0d23646f1bd9f7bce36bd7551
Autor:
Fabio De Gregorio, Arduino A. Mangoni, Giovanni Furlan, Terenzio Ignoni, Marco Tuccori, Hervé Le Louet, Bert van Leeuwen, Nicola Gian Castiglione, Manuela Camisa, Marco Sardella, Anna L. Adams, Paolo Porcelli, Doris Irene Stenver, Glyn Belcher, Elena Prokofyeva, Valentina Mancini, Brian Edwards, Ilaria Grisoni, Mircea Ciuca, Mario Bertazzoli Grabinski Broglio, Margherita D'Antuono, David Chonzi, Laura Boga, Calin Lungu, Christian Rausch, Paola Kruger, Sarah Hall
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety
The collection and assessment of individual case safety reports (ICSRs) is important to detect unknown adverse drug reactions particularly in the first decade after approval of new chemical entities. However, regulations require that these activities
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 53(2)
Lipid emulsion particles containing 10% of medium chain triglycerides were prepared using 2% w/w of a mixture 1:1 w/w of purified soya phosphatidylcholine and 2-hexanoyl phosphatidylcholine as emulsifier mixture, for use as drug carriers. The mean dr